Ana Hanlon-Dearman, MD, MSc, FRCPC, FAAP
In addition to her work at the University of Manitoba, Dr. Ana Hanlon-Dearman is a researcher at the Children's Hospital Research Institute of Manitoba (CHRIM).
Her research focuses on understanding the intersection of neurodevelopmental variation and population health, specifically in the areas of fetal alcohol spectrum disorder (FASD), sleep disorders in neurodevelopmental disorders (NDD), and autism spectrum disorder (ASD).
She is interested in how population-based data can inform our understanding and management of NDD, and its potential for informing people-focused policy.
Dr. Hanlon-Dearman is involved in national research groups such as the CHILDBRIGHT project "Bright Coaching" and Better Nights Better Days for NDD.
Her key publications in FASD include recent population health publications describing the health, social, education, and justice outcomes of children with FASD, a number of papers describing social and systemic risk factors contributing to FASD, and anticipatory guidance for those caring for children and youth with FASD.
She is affiliated with the CanFASD and is a part of the Excellence in Neurodevelopmental and Rehabilitation Research in Child Health, the Specialized Services for Children and Youth (SSCY) Research and Evaluation Committee and Better Nights Better Days.
- Community Health Sciences, Max Rady College of Medicine
- Neurodevelopmental disorders, child
- Fetal alcohol spectrum disorder
- Autism spectrum disorder
- Behavioural sleep disorders
- Neurodevelopmental disorders
- Fetal alcohol spectrum disorder (FASD)
- Autism spectrum disorder (ASD)
- Sleep disorders
- Research scientist, Children’s Hospital Research Institute of Manitoba (CHRIM)
- Excellence in Neurodevelopmental and Rehabilitation Research in Child Health
- Specialized Services for Children and Youth (SSCY) Research and Evaluation Committee
- Better Nights Better Days
Dr. Ana Hanlon-Dearman is a highly accomplished researcher and pediatrician with a wealth of experience in the field of neurodevelopmental disorders, specifically in Fetal Alcohol Spectrum Disorder (FASD).
She is currently the section head of developmental pediatrics and a professor of pediatrics and child health with the University of Manitoba.
Additionally, she is a co-lead in faculty development for the department of pediatrics and child health at the University of Manitoba.
She is a diagnostic co-lead (pediatrics) with CanFASD, a national organization that conducts research on FASD and is involved in FASD research nationally.
Dr. Hanlon-Dearman has led training in FASD multidisciplinary diagnosis and management both nationally and internationally.
She is a research scientist at the Children's Hospital Research Institute of Manitoba (CHRIM) and has a cross-appointment at the Community Health Sciences, Max Rady College of Medicine.
She is involved in national research groups such as the CHILDBRIGHT project "Bright Coaching" and Better Nights Better Days for NDD.
Master of Science (Community Health Sciences), University of Manitoba (2000)
Doctor of Medicine, University of Manitoba (1994)
Bachelor of Nursing, University of Manitoba (1984)
Pediatrics and Child Health
CE-208 Children's Hospital, Health Sciences Centre
840 Sherbrook Street
University of Manitoba
Winnipeg, MB R3A 1S1 Canada